Administration of SPT-siRNA at the time of induction of diabetes in Diab and HF-SD groups (Diab/SPT-si and HF-SD/SPT-si groups) prevented activation of Rac1–Nox2 and increase in ROS levels. The gene discussed is AGXT; the disease is hydrops fetalis.